There Is No Association Between Patient Outcomes and Demographics in an Open-Label Safety and Efficacy Study of RBX2660, a Microbiota-Based Drug for Recurrent Clostridium difficile Infection Article

Full Text via DOI: 10.14309/00000434-201710001-00139 Web of Science: 000439259000137
International Collaboration

Cited authors

  • Ray, Arnab; Hecht, Gail; Orenstein, Robert; Lee, Christine; Dubberke, Erik; Khanna, Sahil; Blount, Ken


Publication date

  • 2017

Published in

International Standard Serial Number (ISSN)

  • 0002-9270

Start page

  • S66

End page

  • S66


  • 112